Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients

The investigators want to validate two non-invasive devices for the determination of central blood pressure, i.e. blood pressure in the aorta (artery leaving the heart).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Blood Pressure Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Aarhus University Hospital, Skejby, Department of Cardiology

Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetes Mellitus, Type 2
Age above 18 years

Exclusion criteria

Atrial fibrillation or other cardiac arrhythmia
known stenosis of aorta or arteria subclavia/brachialis

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Official study title

Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic

Acronym: IMPRESS

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Feb 24, 2012
Registry last updated: Jun 12, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed